News and events

closerlook earns spot on PM360’s list of 2019’s “Greatest Creators”

PM360 - March 2019

closerlook, inc. has been named to PM360’s list of “Greatest Creators” for 2019 for work with Horizon Pharma. The annual showcase highlights some of the best creative work from agencies serving the life science industry. closerlook is featured for our work on the aggNETic Attraction. 

More about the aggNETic Attraction:

In 2018, Horizon launched the aggNET Interactive Visual Aid (IVA), an animated, interactive experience to help the sales team communicate to healthcare professionals (HCPs) how bone erosion can occur in gout despite pain resolution.

In creating awareness of the aggNET story and prompting urgency in treating gout, the aggNET IVA helps physicians identify patients who require a more aggressive gout treatment strategy so they can avoid continued gout progression and bone erosion.

 

Horizon developed the aggNETic Attraction campaign to work within the realities of HCPs’ busy schedules. With a single tap, sales representatives can make brief sales calls more meaningful by navigating to shorter story arcs within the IVA that are most relevant to the HCP being called on.

The success of the aggNET IVA has spurred Horizon to invest in telling the aggNET story across other marketing channels. A branded, interactive, web-based version of the aggNET story, which was developed from the aggNET IVA’s codebase, also launched in 2018.

Throughout the aggNETic Attraction campaign, a host of user-driven decisions made the experience intuitive. Offering an intuitive experience enables each of the aggNET IVA’s primary users—the sales force and rheumatologists—to dedicate more time and attention to the messages within the experience and less time learning how to navigate it.

  

 

See all articles

The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.

Let’s start the conversation. Contact us